Cash Engineering Research company gains its revenue solely from the sale of air compression technology to massive multinationals based in the US and Europe. Its products are intellectual property (IP) - patents and know-how.
IP protection is a crucial component of success for all diagnostic tools. A great example of this is a bowel cancer blood test CSIRO recently developed in conjunction with Clinical Genomics, explains CSIRO Project lead Dr Trevor Lockett.
What does it take to lead a biotech start-up? Try nerves of steel, the patience of a saint, and a brains trust of PhDs and MBAs.
Tom Damin takes us on a tour of Seed Distributors research farm at Virginia, South Australia. He talks about how plant breeder’s rights have helped Seed Distributors cover the cost of producing its unique variety of barley.
Bionomics Limited is set to launch a Phase 2 trial of its anti-anxiety drug BNC210 as a treatment for post-traumatic stress disorder (PTSD).
How do you value biotech startups? It’s not easy. Conventional methods for normal companies rely on discounted cash flows - a fancy term for guessing how much future profit a business will make in today’s dollars.
Phil Sims, CEO of Robern Menz, talks about the value in registering your trade mark and the benefit in seeking advice to confidently invest and protect your brand.
Dr Heather Bray (University of Adelaide), Dr Jane Rathgen (Adelaide Research and Innovation), and Doug Waterhouse (IP Australia) talk all things Plant Breeder's Rights (PBR) on Radio Adelaide.
When someone sees the tagline ‘Just do it!’ they generally know the brand associated with the slogan straight away. It has even been declared as a ‘famous’ trade mark by the Trade Mark Trial & Appeal Board. An important aspect of branding is the customer association and recognition that’s attached to it. Here's what makes Nike's slogan so memorable.
GroundProbe former Chief operating officer (now Vice President Global Operations) David Noon have been conscious from day one of protecting IP rights. David advises organisations to seek early and robust patent advice, but sees patents as just one part of an overall business strategy. Here's why this company doesn't just rely only on a patent.